SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-19-047713
Filing Date
2019-10-09
Accepted
2019-10-08 19:10:35
Documents
8

Document Format Files

Seq Description Document Type Size
1 F-3 tv530771_f3.htm F-3 301500
2 EXHIBIT 5.1 tv530771_ex5-1.htm EX-5.1 12461
3 EXHIBIT 23.1 tv530771_ex23-1.htm EX-23.1 4132
4 GRAPHIC tv530771_img01.jpg GRAPHIC 68179
5 GRAPHIC tv530771_ex5-1img01.jpg GRAPHIC 11767
6 GRAPHIC tv530771_ex5-1img02.jpg GRAPHIC 7900
7 GRAPHIC tv530771_ex23-1img01.jpg GRAPHIC 11534
8 GRAPHIC tv530771_ex23-1img02.jpg GRAPHIC 11668
  Complete submission text file 0001144204-19-047713.txt   472791
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: F-3 | Act: 33 | File No.: 333-234136 | Film No.: 191143517
SIC: 2834 Pharmaceutical Preparations